Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients
Authors:
- 1 July 2016
- journal article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 22 (7) , 607-612
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Preeminence of Staphylococcus aureus in Infective Endocarditis: A 1-Year Population-Based SurveyClinical Infectious Diseases, 2012
- Audit of antibiotic therapy used in 66 cases of endocarditisMedecine Et Maladies Infectieuses, 2011
- Infective endocarditisNature Reviews Cardiology, 2011
- Healthcare-associated infective endocarditis: an undesirable effect of healthcare universalizationClinical Microbiology and Infection, 2010
- Comprehensive Diagnostic Strategy for Blood Culture–Negative Endocarditis: A Prospective Study of 819 New CasesClinical Infectious Diseases, 2010
- Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC)European Heart Journal, 2009
- Staphylococcus aureus EndocarditisJAMA, 2005
- Emergence of endocarditis due to group D streptococci: findings derived from the merged database of the International Collaboration on EndocarditisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Proposed Modifications to the Duke Criteria for the Diagnosis of Infective EndocarditisClinical Infectious Diseases, 2000
- TREATMENT OF RIGHT-SIDED STAPHYLOCOCCUS AUREUS ENDOCARDITIS IN INTRAVENOUS DRUG USERS WITH CIPROFLOXACIN AND RIFAMPICINThe Lancet, 1989